{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:22:12Z","timestamp":1787757732743,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"\n OBJECTIVE:<\/jats:title>\n \n Stress exacerbates the pathophysiology of major neurodegenerative disorders. In this study, the zebrafish (\n Danio rerio<\/jats:italic>\n ), the frequently used model for experimental studies of stress and other central nervous system disorders, was used to evaluate the anxiolytic potential of flavonoids, namely silibinin and naringenin on alleviating acute stress-induced anxiety.\n <\/jats:p>\n <\/jats:sec>\n \n MATERIALS AND METHODS:<\/jats:title>\n A molecular docking study with Molegro Virtual Docker software was done to assess the binding potential of flavonoids on serotonin and dopamine receptors. To determine the bioactivity and investigate the toxicity of the flavonoids, silibinin, and naringenin, brine shrimp lethality assay, and an acute toxicity study was conducted according to Organization for Economic Co-operation and Development (OECD) Test Guideline 203. The effect of silibinin and naringenin was assessed using behavioral tasks such as the novel tank assay and the light-dark test on the zebrafish model of acute stress.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n Molecular docking studies showed a higher affinity of silibinin and naringenin for the serotonin and dopamine receptors. In comparison to the LC\n 50<\/jats:sub>\n value, 13.15 \u03bcg\/ml of the reference standard potassium dichromate, silibinin, and naringenin yielded higher LC\n 50<\/jats:sub>\n values, 34.10 \u03bcg\/ml and 91.33 \u03bcg\/ml, respectively. The LC\n 50<\/jats:sub>\n value of silibinin and naringenin was observed to be >100 mg\/l from the acute toxicity study on adult zebrafish. After transferring to a novel tank, silibinin and naringenin-treated zebrafish groups were found to explore the upper level of the tank, similar to standard drugs, and spent a long time in the upper level of the tank compared to the control group (\n p<\/jats:italic>\n < 0.01). Both silibinin and naringenin treatment group spent increased amounts of time in the tank's illuminated part in contrast to that of the dark side as evidenced by the number of zebrafish entering or remaining in the illuminated part of the tank through the light-dark test. Silibinin and naringenin treated groups were found to spend increased time in the light side significantly on the day 15\n th<\/jats:sup>\n of evaluation as compared to the control group (\n p<\/jats:italic>\n < 0.05 and\n p<\/jats:italic>\n < 0.001, respectively).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n The flavonoids, silibinin, and naringenin were found to mitigate acute stress-induced anxiety, owing to their anxiolytic properties in the zebrafish model and may be explored as the potential therapeutic agents for treating anxiety.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijp.ijp_18_20","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T23:51:20Z","timestamp":1640821880000},"page":"457-464","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Anxiolytic effects of silibinin and naringenin on zebrafish model"],"prefix":"10.4103","volume":"53","author":[{"given":"V.","family":"Nachammai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Jeyabalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20240903","first-page":"199","article-title":"The role of stress in neurodegenerative diseases and mental disorders","volume":"23","author":"Esch","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"R2-4-20240903","doi-asserted-by":"crossref","first-page":"e63302","DOI":"10.1371\/journal.pone.0063302","article-title":"Chronic unpredictable stress (CUS)-induced anxiety and related mood disorders in a zebrafish model: Altered brain proteome profile implicates mitochondrial dysfunction","volume":"8","author":"Chakravarty","year":"2013","journal-title":"PLoS One"},{"key":"R3-4-20240903","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2009.01.016","article-title":"The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury","volume":"484","author":"Vafeiadou","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"R4-4-20240903","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/187153007781662521","article-title":"Neuroinflammation and its modulation by flavonoids","volume":"7","author":"Vafeiadou","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R5-4-20240903","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1590\/S0100-879X2003001200002","article-title":"Neuroprotection by flavonoids","volume":"36","author":"Dajas","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"R6-4-20240903","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin \u2013 New and emerging applications in medicine","volume":"14","author":"Gaz\u00e1k","year":"2007","journal-title":"Curr Med Chem"},{"key":"R7-4-20240903","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2174\/1871520611009030186","article-title":"Silibinin \u2013 A promising new treatment for cancer","volume":"10","author":"Cheung","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"R8-4-20240903","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","article-title":"Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease","volume":"39","author":"Zbarsky","year":"2005","journal-title":"Free Radic Res"},{"key":"R9-4-20240903","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jep.2008.02.015","article-title":"Isolation of the MAO-inhibitor naringenin from Mentha aquatica L","volume":"117","author":"Olsen","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"R10-4-20240903","first-page":"45","article-title":"Neuropharmacological effects of naringenin, harmine and adenosine on parkinsonism induced in rats","volume":"8","author":"El Madani","year":"2016","journal-title":"Pharm Lett"},{"key":"R11-4-20240903","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2010.05.010","article-title":"The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases","volume":"40","author":"Panula","year":"2010","journal-title":"Neurobiol Dis"},{"key":"R12-4-20240903","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuropharm.2013.03.006","article-title":"Role of serotonin in zebrafish (Danio rerio) anxiety: Relationship with serotonin levels and effect of buspirone, WAY 100635, SB 224289, fluoxetine and para-chlorophenylalanine (pCPA) in two behavioral models","volume":"71","author":"Maximino","year":"2013","journal-title":"Neuropharmacology"},{"key":"R14-4-20240903","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.06.022","article-title":"Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish","volume":"205","author":"Egan","year":"2009","journal-title":"Behav Brain Res"},{"key":"R15-4-20240903","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.pnpbp.2011.01.006","article-title":"Pharmacological analysis of zebrafish (Danio rerio) scototaxis","volume":"35","author":"Maximino","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R16-4-20240903","first-page":"e3790","article-title":"Long-term lethal toxicity test with the crustacean Artemia franciscana","volume":"62","author":"Manfra","year":"2012","journal-title":"JoVE (Journal of Visualized Experiments"},{"key":"R17-4-20240903","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbr.2015.09.027","article-title":"Fluoxetine and diazepam acutely modulate stress induced-behavior","volume":"296","author":"Giacomini","year":"2016","journal-title":"Behav Brain Res"},{"key":"R18-4-20240903","doi-asserted-by":"crossref","first-page":"15081","DOI":"10.1038\/s41598-017-15374-w","article-title":"Establishing zebrafish as a model to study the anxiolytic effects of scopolamine","volume":"7","author":"Hamilton","year":"2017","journal-title":"Sci Rep"},{"key":"R19-4-20240903","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pharep.2013.06.012","article-title":"Oral dosing in adult zebrafish: Proof-of-concept using pharmacokinetics and pharmacological evaluation of carbamazepine","volume":"66","author":"Kulkarni","year":"2014","journal-title":"Pharmacol Rep"},{"key":"R20-4-20240903","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2009.225","article-title":"Scototaxis as anxiety-like behavior in fish","volume":"5","author":"Maximino","year":"2010","journal-title":"Nat Protoc"},{"key":"R21-4-20240903","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tins.2014.02.011","article-title":"Zebrafish models for translational neuroscience research: From tank to bedside","volume":"37","author":"Stewart","year":"2014","journal-title":"Trends Neurosci"},{"key":"R22-4-20240903","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1126\/science.1197410","article-title":"Structure of the human dopamine D3 receptor in complex with a D2\/D3 selective antagonist","volume":"330","author":"Chien","year":"2010","journal-title":"Science"},{"key":"R23-4-20240903","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2007-971236","article-title":"Brine shrimp: A convenient general bioassay for active plant constituents","volume":"45","author":"Meyer","year":"1982","journal-title":"Planta Med"},{"key":"R24-4-20240903","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-0711-8-16","article-title":"Studies on the antimicrobial activity and brine shrimp toxicity of Zeyheria tuberculosa (Vell.) Bur. (Bignoniaceae) extracts and their main constituents","volume":"8","author":"Bastos","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R26-4-20240903","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acschemneuro.7b00110","article-title":"Inhibition of A\u03b2 amyloid growth and toxicity by silybins: The crucial role of stereochemistry","volume":"8","author":"Sciacca","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"R27-4-20240903","first-page":"184","article-title":"Evaluate neuroprotective effect of silibinin using chronic unpredictable stress (cus) model","volume":"10","author":"Garikapati","year":"2018","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"R28-4-20240903","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fphar.2017.00340","article-title":"A systematic strategy for discovering a therapeutic drug for Alzheimer's disease and its target molecule","volume":"8","author":"Yang","year":"2017","journal-title":"Front Pharmacol"},{"key":"R29-4-20240903","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/B978-0-12-817905-5.00008-1","article-title":"Naringenin (4, 5, 7-trihydroxyflavanone) as a potent neuroprotective agent: From chemistry to medicine","volume":"65","author":"Amin","year":"2020","journal-title":"Stud Natl Prod Chem"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_18_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:52:09Z","timestamp":1787755929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_18_20"}},"subtitle":["A preclinical study"],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_18_20","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}